Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life and few show cardiovascular benefits at one year, finds a new study in The BMJ https://bit.ly/4gmXim6 Read the linked commentary https://bit.ly/4f67A7I

18 likes 0 replies